Epilepsy Clinical Trial
Official title:
A Multicenter, Open Label, Crossover Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Adult Subjects With Epilepsy
This Phase 2 open-label, two-way study was conducted in adult subjects with epilepsy who were on stable regimens of anti-epileptic drugs (AEDs) and who were admitted to an Epilepsy Monitoring Unit (EMU), General Clinical Research Center (GCRC), or similar facility for evaluation of their seizures. All subjects received a single DBF 12.5 mg dose during the Interictal State and a single DBF 12.5 mg dose during the Ictal/peri-ictal state with at least 14 days washout between the 2 doses.
This was a Phase 2 multicenter, open-label, two-way study conducted in adult subjects to
assess the bioavailability, pharmacokinetics, and safety of DBF during the Interictal Period
and during the Ictal/peri-ictal Period, with a minimum of 14 days of washout between periods.
Subjects had a clinical diagnosis of epilepsy (with generalized tonic-clonic seizures or
focal seizures with impaired awareness) who were on stable regimens of anti-epileptic drugs
and were scheduled for admission to an EMU, GCRC, or similar facility for evaluation.
All subjects were to receive a single 12.5-mg dose of study drug, without regard to meals,
during both Interictal Period and Ictal/peri-ictal Period. The treatment was identical for
both periods. Treatment sequence was not randomized. The interictal period and
ictal/peri-ictal could occur in either order as determined by seizure occurrence.
Interictal Period: Subjects were considered to be in an interictal state if an interval of at
least 3 hours had elapsed since any clinically observable postictal signs or symptoms (from
the last observed seizure) and the subject had been seizure-free over this period. Subjects
on electroencephalogram (EEG) video monitoring were to be considered to be in an interictal
state if an interval of at least 3 hours had elapsed since there were any postictal
electrical findings on EEG.
Ictal/peri-ictal Period: For the purposes of this study, the ictal state was defined as an
ongoing clinically observable seizure or seizure activity as verified via EEG. The periictal
state was defined clinically as the subject's immediate postictal state following a
generalized tonic-clonic (GTC) seizure or focal seizure with impaired awareness, and within 5
minutes following the last clonic jerk. For subjects on EEG video monitoring, the periictal
state was to be defined as less than 5 minutes after cessation of seizure activity as
verified via EEG.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04595513 -
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
|
Phase 1/Phase 2 | |
Completed |
NCT02909387 -
Adapting Project UPLIFT for Blacks in Georgia
|
N/A | |
Completed |
NCT05552924 -
Self Acupressure on Fatigue and Sleep Quality in Epilepsy Patients
|
N/A | |
Terminated |
NCT01668654 -
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
|
Phase 3 | |
Not yet recruiting |
NCT05068323 -
Impact of Interictal Epileptiform Activity on Some Cognitive Domains in Newly Diagnosed Epileptic Patients
|
N/A | |
Completed |
NCT03994718 -
Creative Arts II Study
|
N/A | |
Recruiting |
NCT04076449 -
Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy
|
||
Completed |
NCT00782249 -
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Recruiting |
NCT05101161 -
Neurofeedback Using Implanted Deep Brain Stimulation Electrodes
|
N/A | |
Active, not recruiting |
NCT06034353 -
Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients
|
N/A | |
Recruiting |
NCT05769933 -
Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
|
||
Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
Not yet recruiting |
NCT05559060 -
Comorbidities of Epilepsy(Cognitive and Psychiatric Dysfunction)
|
||
Completed |
NCT02977208 -
Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use
|
Phase 4 | |
Completed |
NCT02646631 -
Behavioral and Educational Tools to Improve Epilepsy Care
|
N/A | |
Completed |
NCT02952456 -
Phenomenological Approach of Epilepsy in Patients With Epilepsy
|
||
Recruiting |
NCT02539134 -
TAK-935 Multiple Rising Dose Study in Healthy Participants
|
Phase 1 | |
Completed |
NCT02491073 -
Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)
|
N/A | |
Terminated |
NCT02757547 -
Transcranial Magnetic Stimulation for Epilepsy
|
N/A |